To access whether increasing the intratumoral proportion and enhancing function of CD8+ T cells in IFI35-overexpressing tumor resulted in improving efficacy of immunotherapy, we established multiple models combining with IFI35 overexpression, seeking to uncover that IFI35 may enhance the efficacy of immunotherapy. The gene discussed is IFI35; the disease is neoplasm.